Keyphrases
Anti-Mllerian Hormone
18%
Anti-mullerian Hormone Levels
24%
Anti-Müllerian Hormone
20%
Biological Age
22%
Body Mass Index
28%
Cancer Patients
16%
Controlled Ovarian Stimulation
40%
DNA Methylation (DNAm)
32%
Endometrial Cells
11%
Endometrial Tissue
28%
Endometriosis
100%
Endometrium
20%
Female Cancer Patients
10%
Follicular Fluid
11%
Free Androgen Index
10%
Gallic Acid
11%
Gene Expression
14%
Granulosa Cells
14%
Hormone Levels
21%
In Vitro Fertilization
77%
Indonesia
34%
Indonesian
16%
Indonesian Women
11%
Infertile Women
19%
Infertility
28%
Insulin Resistance
11%
Jakarta
26%
Luteinizing Hormone Receptor
10%
Macaca Nemestrina
26%
Menopausal Symptoms
17%
Methylation Profile
10%
Methylation Status
31%
MRNA Expression
33%
No Significant Difference
10%
Oocyte Maturation
16%
Oocyte Quality
24%
Ovarian Endometriosis
32%
Ovarian Reserve
15%
Ovarian Stimulation
11%
Ovarium
15%
Peritoneal Endometriosis
27%
Polycystic Ovary Syndrome
42%
Poor Responders
22%
Progesterone Receptor
16%
Progesterone Receptor Gene
10%
Promoter Methylation
11%
Quality of Life
12%
Receptor Expression
13%
Recombinant Human Follicle-stimulating Hormone (r-hFSH)
18%
Yasmin
12%
Medicine and Dentistry
Androgen
15%
Aneuploidy
6%
Antral Follicle
7%
Assisted Reproductive Technology
9%
Body Mass Index
29%
Childbirth
6%
Chorionic Gonadotropin
10%
Controlled Ovarian Hyperstimulation
13%
COVID-19
6%
Cross Sectional Study
60%
DNA Methylation
8%
DNA Polymorphism
10%
Drospirenone Plus Ethinylestradiol
17%
Endometriosis
81%
Endometrium
17%
Fertility Preservation
11%
Fertilization
8%
Gene Expression
12%
Granulosa Cell
27%
Growth Differentiation Factor 9
14%
Hormone Determination
37%
Hyperandrogenism
13%
In Vitro
6%
In Vitro Fertilisation
89%
Insulin Resistance
14%
Luteinizing Hormone Receptor
10%
Malignant Neoplasm
17%
Maternal Mortality
7%
Menopausal Symptom
6%
Methylation
31%
Muellerian Inhibiting Factor
37%
Oocyte
64%
Oocyte Maturation
16%
Ovarian Reserve
8%
Peritoneum
6%
Polycystic Ovarian Syndrome
10%
Polycystic Ovary Syndrome
41%
Pregnancy Rate
8%
Progesterone Receptor
13%
Progesterone Receptor B
10%
Promoter Region
13%
Randomized Clinical Trial
10%
Receptor Expression
15%
Receptor Gene
15%
Recombinant Follitropin
13%
Reproductive Medicine
8%
Reproductive Public Health
15%
Symptom
11%
Testosterone
6%
Triacylglycerol
10%